Article
Decoding MASLD Progression: A Molecular Trajectory-Based Framework for Modelling Disease Dynamics
2025-01-18
Abstract excerpt
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has emerged as a silent pandemic, affecting nearly one-third of the global population. MASLD encompasses a spectrum of liver disorders, ranging from simple steatosis to Metabolic Dysfunction-Associated Steatohepatitis (MASH), characterised by lipotoxicity, hepatocellular injury, inflammation, and fibrosis, which can eventually progress to cirrhosis a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c3c7c2f5-bedf-5358-a230-a076d96e7beb
- DOI
- 10.1101/2025.01.14.632908
